MedPath

Sublingual Administration of PPI

Conditions
Gastric or Duodenal Ulcer
Registration Number
NCT01926600
Lead Sponsor
The Catholic University of Korea
Brief Summary

Compare 24-hour intragastric pH and therapeutic effectiveness of proton pump inhibitor (PPI) among different administration methods: per oral (PO), intravenous (IV), and sublingual (SL).

Detailed Description

Intragastric pH and therapeutic effectiveness of PPI was compared among patients given PPI with different administration methods. 24 hour intragastric pH catheter was inserted in stomach of patients with peptic ulcer an hour prior to PPI administration in order to observe the initial change in pH. Three groups of patients were given PPI through per oral, intravenous, and sublingual administration methods. The hypothesis of this study is that sublingual administration will be faster than oral or IV administration in PPI dosing with respect to intragastric pH change and re-bleeding rate.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients with peptic ulcer disease
  • Age: 20-75 years old
  • Patients who submitted informed consent
Exclusion Criteria
  • Peptic ulcer disease with spurting and oozing
  • Shock, hypotension, pregnancy
  • Gastrointestinal malignancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure 24-hour intragastric pH24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St.Mary's Hopspital of the Catholic University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath